Mannkind (MNKD) Other Non-Current Assets (2010 - 2026)
Mannkind's (MNKD) quarterly Other Non-Current Assets came in at $747000.0 in Q1 2026, up 1.08% year-on-year from $739000.0 in Q1 2025, and down 96.29% on a QoQ basis from $20.1 million in Q4 2025.
Mannkind (MNKD) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Other Non-Current Assets data on file, last reported at $747000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 1.08% year-over-year to $747000.0 in Q1 2026; TTM through Mar 2026 was $747000.0, a 1.08% increase from a year earlier, with the FY2025 full-year figure at $20.1 million, up 2631.21% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $747000.0, down from $20.1 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for MNKD reached as high as $20.1 million in Q4 2025 and fell as low as $732000.0 in Q2 2024.
- Historically, Other Non-Current Assets has averaged $8.7 million across 5 years, with a median of $8.0 million in 2023.
- Across the five-year window, Other Non-Current Assets tumbled 91.24% in 2024 and jumped 2631.21% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $9.7 million in 2022, then retreated by 23.59% to $7.4 million in 2023, then tumbled by 90.08% to $737000.0 in 2024, then soared by 2631.21% to $20.1 million in 2025, then plunged by 96.29% to $747000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $747000.0 in Q1 2026, $20.1 million in Q4 2025, and $19.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | 747,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 747,000.00 |
| Dec 31, 2025 | 20.13 Mn |
| Sep 30, 2025 | 19.13 Mn |
| Jun 30, 2025 | 741,000.00 |
| Mar 31, 2025 | 739,000.00 |
| Dec 31, 2024 | 737,000.00 |
| Sep 30, 2024 | 735,000.00 |
| Jun 30, 2024 | 732,000.00 |
| Mar 31, 2024 | 7.45 Mn |
| Dec 31, 2023 | 7.43 Mn |
| Sep 30, 2023 | 8.05 Mn |
| Jun 30, 2023 | 8.35 Mn |
| Mar 31, 2023 | 16.38 Mn |
| Dec 31, 2022 | 9.72 Mn |
| Sep 30, 2022 | 17.31 Mn |
| Jun 30, 2022 | 17.51 Mn |
| Mar 31, 2022 | 12.06 Mn |
| Dec 31, 2021 | 8.44 Mn |
| Sep 30, 2021 | 6.09 Mn |
| Jun 30, 2021 | 5.80 Mn |